Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
High-grade serous ovarian cancers (HGS-OvCa) frequently develop chemotherapy resistance. Here, the authors through a systematic analysis of proteomic and drug response data of 14 HGS-OvCa PDXs demonstrate that targeting apoptosis regulators can improve response of these tumors to inhibitors of the P...
Guardado en:
Autores principales: | Ioannis K. Zervantonakis, Claudia Iavarone, Hsing-Yu Chen, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula Matulonis, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bef99f7f9cf545ffab161533fef245e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
por: Jason J. Zoeller, et al.
Publicado: (2017) -
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer
por: Marcel A. Dammert, et al.
Publicado: (2019) -
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
por: Steven Lohard, et al.
Publicado: (2020) -
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
por: Nicolai Juul Birkbak, et al.
Publicado: (2013) -
Apoptotic Genes’ Expression in an Ovarian Cancer Cell Line (A2780) Exposed to Green Synthesized Cerium Oxide Nanoemulsion
por: Mohammad Ashna, et al.
Publicado: (2021)